Viatris Income After Taxes 2010-2024 | VTRS

Viatris annual/quarterly income after taxes history and growth rate from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
  • Viatris income after taxes for the quarter ending September 30, 2024 was $0.095B, a 71.41% decline year-over-year.
  • Viatris income after taxes for the twelve months ending September 30, 2024 was $-0.883B, a 148.23% decline year-over-year.
  • Viatris annual income after taxes for 2023 was $0.055B, a 97.37% decline from 2022.
  • Viatris annual income after taxes for 2022 was $2.079B, a 263.79% decline from 2021.
  • Viatris annual income after taxes for 2021 was $-1.269B, a 89.45% increase from 2020.
Viatris Annual Income After Taxes
(Millions of US $)
2023 $55
2022 $2,079
2021 $-1,269
2020 $-670
2019 $17
2018 $353
2017 $696
2016 $480
2015 $848
2014 $933
2013 $627
2012 $643
2011 $539
2010 $346
2009 $248
Viatris Quarterly Income After Taxes
(Millions of US $)
2024-09-30 $95
2024-06-30 $-326
2024-03-31 $114
2023-12-31 $-766
2023-09-30 $332
2023-06-30 $264
2023-03-31 $225
2022-12-31 $1,011
2022-09-30 $354
2022-06-30 $314
2022-03-31 $399
2021-12-31 $-264
2021-09-30 $312
2021-06-30 $-279
2021-03-31 $-1,038
2020-12-31 $-916
2020-09-30 $186
2020-06-30 $39
2020-03-31 $21
2019-12-31 $21
2019-09-30 $190
2019-06-30 $-169
2019-03-31 $-25
2018-12-31 $51
2018-09-30 $177
2018-06-30 $38
2018-03-31 $87
2017-12-31 $244
2017-09-30 $88
2017-06-30 $297
2017-03-31 $66
2016-12-31 $418
2016-09-30 $-120
2016-06-30 $168
2016-03-31 $14
2015-12-31 $195
2015-09-30 $429
2015-06-30 $168
2015-03-31 $57
2014-12-31 $191
2014-09-30 $499
2014-06-30 $127
2014-03-31 $117
2013-12-31 $181
2013-09-30 $159
2013-06-30 $179
2013-03-31 $108
2012-12-31 $162
2012-09-30 $212
2012-06-30 $139
2012-03-31 $129
2011-12-31 $130
2011-09-30 $157
2011-06-30 $147
2011-03-31 $105
2010-12-31 $21
2010-09-30 $144
2010-06-30 $87
2010-03-31 $94
2009-12-31 $47
2009-09-30 $-4
2009-06-30 $96
2009-03-31 $109
Sector Industry Market Cap Revenue
Medical Medical Services $15.624B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $98.658B 12.24
Cencora (COR) United States $49.082B 18.10
DiDi Global (DIDIY) China $23.427B 0.00
ICON (ICLR) Ireland $17.504B 15.59
Natera (NTRA) United States $16.570B 0.00
Avantor (AVTR) United States $15.178B 22.75
Revvity (RVTY) United States $14.682B 25.50
BioMerieux (BMXMF) France $13.087B 0.00
CochLear (CHEOY) Australia $12.998B 0.00
Solventum (SOLV) United States $12.357B 0.00
Doximity (DOCS) United States $11.372B 67.31
Medpace Holdings (MEDP) United States $11.301B 31.84
Charles River Laboratories (CRL) United States $11.285B 21.81
HealthEquity (HQY) United States $8.756B 47.52
Sonic Healthcare (SKHHY) Australia $8.590B 0.00
Bausch + Lomb (BLCO) Canada $7.202B 33.53
Life Times (LTH) United States $5.139B 34.01
Sotera Health (SHC) United States $4.509B 24.12
Organon (OGN) United States $4.144B 4.18
Surgery Partners (SGRY) United States $3.996B 44.27
BrightSpring Health Services (BTSG) United States $3.489B 74.22
PACS (PACS) United States $3.347B 0.00
Alignment Healthcare (ALHC) United States $2.580B 0.00
Concentras Parent (CON) United States $2.505B 0.00
Ardent Health Partners (ARDT) United States $2.471B 0.00
Premier (PINC) United States $2.314B 11.55
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $2.016B 0.00
GoodRx Holdings (GDRX) United States $1.856B 48.90
Teladoc Health (TDOC) United States $1.689B 0.00
Progyny (PGNY) United States $1.540B 27.08
Pediatrix Medical (MD) United States $1.371B 13.41
Establishment Labs Holdings (ESTA) $1.266B 0.00
CareDx (CDNA) United States $1.252B 0.00
AMN Healthcare Services Inc (AMN) United States $1.058B 7.16
Embecta (EMBC) United States $0.910B 6.07
Agilon Health (AGL) United States $0.890B 0.00
InnovAge Holding (INNV) United States $0.809B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.723B 0.00
Auna S.A (AUNA) Luxembourg $0.516B 0.00
Sonida Senior Living (SNDA) United States $0.459B 0.00
DocGo (DCGO) United States $0.411B 15.46
Enhabit (EHAB) United States $0.403B 34.83
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
LifeMD (LFMD) United States $0.308B 0.00
Sera Prognostics (SERA) United States $0.248B 0.00
ModivCare (MODV) United States $0.231B 12.54
Beauty Health (SKIN) United States $0.218B 0.00
Biodesix (BDSX) United States $0.205B 0.00
Nutex Health (NUTX) United States $0.152B 0.00
MultiPlan (MPLN) United States $0.137B 0.00
Ascend Wellness Holdings (AAWH) United States $0.107B 0.00
So-Young (SY) China $0.088B 21.28
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.054B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.042B 1.10
Co-Diagnostics (CODX) United States $0.038B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00